论文部分内容阅读
早期和晚期卵巢恶性肿瘤的称谓尚未统一，有些学者认为，早期（ｅａｒｌｙ，ｏｐｔｉｍａｌ，ｆａｖｏｒａｂｌｅ）卵巢恶性肿瘤是指ＦＩＧＯⅠ～Ⅱ期、残余瘤＜１～２ｃｍ，甚至包括Ⅲ期经肿瘤减灭术后最大残余瘤直径＜１ｃｍ者；晚期则指Ⅲ～Ⅳ期而且术后有大块残余瘤者。１９９４年美国国立卫生研究院（ＮＩＨ）召开的卵巢癌专题会议中使用的早期卵巢癌仅指Ⅰ期，其余皆为晚期癌，沿用这一标准，在每年新增加的卵巢癌患者中１／３为早期患者，但死亡率仍达３０％～４０％。因此，慎重而合理地处理非常重要。现就早期上皮性（Ⅰ期）卵巢癌、恶性生殖细胞卵巢肿瘤与恶性性腺间质卵巢肿瘤的处理作一综述。
Early and late ovarian malignancies have not been standardized. Some scholars believe that early, optimal, favorable ovarian malignancies are FIGO stage Ⅰ ~ Ⅱ, residual tumor <1 ~ 2 cm, and even Ⅲ stage after tumor reduction The largest residual tumor diameter <1cm were; late refers to the stage Ⅲ ~ Ⅳ and postoperative residual large tumor who. Early ovarian cancer used in the ovarian cancer symposium held by the National Institutes of Health (NIH) in 1994 refers only to stage I and the rest are all advanced cancers. With this standard, 1/3 of the newly increased ovarian cancer patients each year For the early patients, but the mortality rate is still up to 30% to 40%. Therefore, it is very important to handle it carefully and reasonably. Now on the early epithelial (Ⅰ) ovarian cancer, malignant germ cell ovarian tumors and malignant gland stromal ovarian tumors were reviewed.